SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001013594-19-000164
Filing Date
2019-02-14
Accepted
2019-02-14 11:43:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 14, 2019 aldeyra13ga-021419.htm SC 13G/A 92180
  Complete submission text file 0001013594-19-000164.txt   93904
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88182 | Film No.: 19603049
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A